Abstract:Healthy lifespan can be extended in eukaryotes by dietary restriction (DR). In Drosophila, DR of essential amino acids (EAAs) extends lifespan, which is thought to be dependent on the Target of Rapamycin (TOR) pathway, but the transcriptional bases of these effects are poorly understood. Identifying these transcriptional changes and their regulators offers the prospect of correctly coordinating physiology to mimic the benefits of DR. We have analysed how DR and TOR alter transcriptional networks in adult female Drosophila, by specifically diluting EAAs or adding the TOR-suppressive drug rapamycin and analysing the transcriptomes of dissected organs. This network analysis simplified the description of the organ system by two orders of magnitude whilst retaining ~80% of information. The broad transcriptional effects of DR were recapitulated by rapamycin, indicating that DR exerts its transcriptional effects via TOR. At a finer resolution, one particular transcriptional module was associated with transcriptional changes induced by both DR and rapamycin, suggesting a general anti-ageing role for this module. However there were also treatment-specific effects of both DR and rapamycin, with the important implication that not all transcriptional effects of TOR suppression are obligately coupled, which may offer the possibility of separating lifespan benefits from costs of intervention. These changes across organs were mirrored by changes within organs. Lifespan-associated transcriptional changes were strongly associated with binding sites for GATA transcription factors, providing a candidate mechanism to regulate the observed transcriptional effects of diet. Collectively these results show that diet and TOR signaling have extensive effects on transcription across organs, isolate transcriptional changes that may be generally associated with longevity from other effects of DR and of drugs, and show that the genes associated with lifespan extension are enriched in GATA motifs.

Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling

Dietary Restriction Extends Lifespan through Metabolic Regulation of Innate Immunity

Hif-1 Modulates Dietary Restriction-Mediated Lifespan Extension Via Ire-1 In Caenorhabditis Elegans

ACS-20/FATP4 mediates the anti-ageing effect of dietary restriction in C. elegans

The conserved microRNA-229 family controls low-insulin signaling and dietary restriction induced longevity through interactions with SKN-1/NRF2

Towards Understanding the Lifespan Extension by Reduced Insulin Signaling: Bioinformatics Analysis of Daf-16/Foxo Direct Targets in Caenorhabditis Elegans

Reduced Expression of C/EBPβ-LIP Extends Health- and Lifespan in Mice

Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans

Advances in Sirtuin on the Mechanism of Calorie Restriction on Lifespan*

Dopamine D1- and D2-like Receptors Oppositely Regulate Lifespan Via a Dietary Restriction Mechanism in Caenorhabditis Elegans

Methyl 3,4-Dihydroxybenzoate Enhances Resistance to Oxidative Stressors and Lifespan in C. elegans Partially via daf-2/daf-16

Elucidating the effective age for dietary restriction and the key metabolites involved

Target of Rapamycin Signalling Mediates the Lifespan-Extending Effects of Dietary Restriction by Essential Amino Acid Alteration

Genetic and metabolomic architecture of variation in diet restriction-mediated lifespan extension in Drosophila

Molecular mechanisms of dietary restriction in aging—insights from Caenorhabditis elegans research

Lifespan extension by dietary restriction in Drosophila is associated with GATA motifs and organ-specific, TOR-dependent transcriptional networks.

Calorie restriction increases insulin sensitivity to promote beta cell homeostasis and longevity in mice

HSB-1 Inhibition and HSF-1 Overexpression Trigger Overlapping Transcriptional Changes To Promote Longevity in Caenorhabditis elegans

Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

The ACE inhibitor captopril inhibits ACN-1 to control dauer formation and aging

Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age